Cellspex
Cell spectroscopy systems and enzyme simulation software for researchers studying mitochondrial bioenergetics
Highlights
- Young companyFounded 2024
- New on EvolcAdded 2026-11-07
About Cellspex
CellSpex offers the Iberius cell spectroscopy system, which measures intramitochondrial potentials using optical spectroscopy, and software for simulating enzyme electron transfer and proton pumping in the electron transfer chain.
The company focuses on mitochondrial bioenergetics and the role of mitochondria in cell function. It is CELLSPEX LTD, founded in 2024 and registered in Northampton, United Kingdom.
Product: The Iberius cell spectroscopy system measures intramitochondrial potentials, and enzyme simulation software models electron transfer and proton pumping.
Jobs at Cellspex
More biotech & pharma companies
Centauri Therapeutics
Develops Alphamer immunotherapies for infectious diseases, including Gram-negative bacterial infections in high-risk patientsNew on EvolcCerevance
Develops cell-type-specific therapies and drug targets for patients with neurodegenerative, psychiatric and CNS disordersNew on EvolcChemify
Automated chemistry systems that help pharmaceutical and materials partners design and synthesize moleculesNew on EvolcChugai Pharma Europe
European pharmaceutical operations and product support for patients and medical communities across the regionNew on EvolcCiteab
Provides citation-based reagent search and life science data services for researchers and life science suppliersNew on EvolcCizzle Biotechnology
Non-invasive blood test for early lung cancer detection based on the CIZ1B biomarker, aimed at healthcare providers and patientsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.